Macquarie Group Portfolio holdings
AUM
$81.5B
1-Year Return
21.2%
This Quarter Return
+22.75%
1 Year Return
+21.2%
3 Year Return
+85%
5 Year Return
+166.7%
10 Year Return
+339.95%
AUM
$68.5B
AUM Growth
+$9.41B
(+16%)
Cap. Flow
-$814M
Cap. Flow
% of AUM
-1.19%
Top 10 Holdings %
Top 10 Hldgs %
11.5%
Holding
2,426
New
97
Increased
651
Reduced
820
Closed
64
Top Buys
| 1 |
DFS
Discover Financial Services
DFS
|
+$744M |
| 2 |
Viatris
VTRS
|
+$699M |
| 3 |
Honeywell
HON
|
+$668M |
| 4 |
MIC
Macquarie Infrastructure Holdings, LLC
MIC
|
+$524M |
| 5 |
Lyft
LYFT
|
+$219M |
Top Sells
| 1 |
Bank of New York Mellon
BK
|
+$739M |
| 2 |
Pfizer
PFE
|
+$697M |
| 3 |
Marsh & McLennan
MMC
|
+$627M |
| 4 |
Walt Disney
DIS
|
+$177M |
| 5 |
Truist Financial
TFC
|
+$136M |
Sector Composition
| 1 | Technology | 18.63% |
| 2 | Healthcare | 15.47% |
| 3 | Financials | 13.03% |
| 4 | Industrials | 11.38% |
| 5 | Consumer Discretionary | 9.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1201
Haverty Furniture Companies
HVT
$371M
| $1.25M | ﹤0.01% |
45,321
| – | – |
|
1202
ZTO Express
ZTO
$15.2B
| $1.25M | ﹤0.01% |
42,785
+3,445
| +9% | +$100K |
|
1203
Theravance Biopharma
TBPH
$720M
| $1.25M | ﹤0.01% |
70,058
+18,675
| +36% | +$332K |
|
1204
Corpay
CPAY
$21.7B
| $1.24M | ﹤0.01% |
4,552
-4,341
| -49% | -$1.18M |
|
1205
Broadridge
BR
$29.5B
| $1.24M | ﹤0.01% |
8,087
-800
| -9% | -$123K |
|
1206
Assured Guaranty
AGO
$3.93B
| $1.23M | ﹤0.01% |
39,155
| – | – |
|
1207
Verisk Analytics
VRSK
$36.6B
| $1.22M | ﹤0.01% |
5,896
+1,892
| +47% | +$393K |
|
1208
Trinseo
TSE
$87.7M
| $1.22M | ﹤0.01% |
23,755
| – | – |
|
1209
Aon
AON
$80.2B
| $1.21M | ﹤0.01% |
5,746
-2,181
| -28% | -$461K |
|
1210
Penske Automotive Group
PAG
$11.9B
| $1.21M | ﹤0.01% |
20,438
| – | – |
|
1211
Regions Financial
RF
$24.2B
| $1.21M | ﹤0.01% |
75,334
-22,200
| -23% | -$358K |
|
1212
Altria Group
MO
$112B
| $1.21M | ﹤0.01% |
29,475
+20,500
| +228% | +$841K |
|
1213
OGE Energy
OGE
$8.96B
| $1.21M | ﹤0.01% |
37,951
-5,248
| -12% | -$167K |
|
|
CLVS
1214
DELISTED
Clovis Oncology, Inc.
CLVS
| $1.21M | ﹤0.01% |
251,458
| – | – |
|
1215
argenx
ARGX
$46.3B
| $1.2M | ﹤0.01% |
4,066
| – | – |
|
1216
Cathay General Bancorp
CATY
$3.39B
| $1.2M | ﹤0.01% |
37,099
| – | – |
|
|
PRVB
1217
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $1.19M | ﹤0.01% |
70,000
| – | – |
|
1218
Vanguard S&P 500 ETF
VOO
$740B
| $1.19M | ﹤0.01% |
+3,450
| New | +$1.19M |
|
1219
Invesco
IVZ
$10B
| $1.18M | ﹤0.01% |
67,925
+18,660
| +38% | +$325K |
|
1220
Intellia Therapeutics
NTLA
$1.23B
| $1.18M | ﹤0.01% |
21,773
| – | – |
|
|
RSX
1221
DELISTED
VanEck Russia ETF
RSX
| $1.18M | ﹤0.01% |
+48,786
| New | +$1.18M |
|
1222
Verra Mobility
VRRM
$3.92B
| $1.17M | ﹤0.01% |
87,446
-6,699
| -7% | -$89.9K |
|
1223
ArcBest
ARCB
$1.6B
| $1.17M | ﹤0.01% |
+27,300
| New | +$1.17M |
|
1224
News Corp Class B
NWS
$18.2B
| $1.16M | ﹤0.01% |
65,470
+61,470
| +1,537% | +$1.09M |
|
1225
Cerus
CERS
$236M
| $1.16M | ﹤0.01% |
167,465
-25,840
| -13% | -$179K |
|